Crossmark

Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling

Crossref DOI link: https://doi.org/10.1186/s11658-022-00370-4

Published Online: 2022-09-23

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wen, Jingyuan

Huang, Zhao

Wei, Yi

Xue, Lin

Wang, Yufei

Liao, Jingyu

Liang, Junnan

Chen, Xiaoping

Chu, Liang

Zhang, Bixiang https://orcid.org/0000-0002-1609-7260
Funding

Funding for this research was provided by:

Innovative Research Group Project of the National Natural Science Foundation of China (82172971, 31671348, 81874189)

Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province (CXPJJH12000001-2020317)

National Major Science and Technology Projects of China ((2018ZX10723204-003)

Key Technologies Research and Development Program (2018YFA0208904)

Fundamental Research Funds for the Central Universities, HUST (2020JYCXJJ019)
License Information

Text and Data Mining valid from 2022-09-23

Version of Record valid from 2022-09-23
More Information

Article History

Received: 3 April 2022

Accepted: 4 August 2022

First Online: 23 September 2022

Declarations

:

: All animal experimental procedures were performed in accordance with the Basel Declaration, and was also approved by the Committee on the Ethics of Animal Experiments of Tongji Hospital (TJH-202005005, 2 March 2020). All human tissue samples were obtained in accordance with the Declaration of Helsinki (1975), and were approved by the ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China) (TJ-IRB20211163, 30 November 2021).

: Not applicable.

: The authors declare that there are no conflicts of interest.

Document is current

Any future updates will be listed below